The long-term objective is to understand the mechanism of insulin resistance in NIDDM and obesity. The significance of this proposal is three fold: (i) A method to culture insulin responsive human adipocytes in serum-free medium has been developed; (ii) We have a well defined human model of NIDDM. Our institution performs over 100 gastric bypass procedures annually in morbidly obese subjects of whom 27% have NIDDM, 20% impaired, and the rest have normal glucose tolerance; and (iii) Following gastric bypass, these patients effectively loose weight and 75% of NIDDM patients are able to maintain euglycemia without therapy. First, we will determine insulin sensitivity and responsiveness of insulin actions in adipocytes from our patients. The decreased insulin binding in obesity and NIDDM is explained by insulin receptor turnover and mRNA levels. Then, the structure and function (in vitro and in vivo phosphorylation of B-subunit and endogenous substrate) of insulin receptor is analyzed to evaluate its role as a transducer of insulin action. Monoclonal antibodies are also used to probe the significance insulin receptor kinase in NIDDM and obesity. The mechanism of decreased glucose transport in obese and NIDDM patients is studied by determining the number, intracellular distribution, intrinsic activity and mRNA levels of glucose transporters. Primary cultures of adipocytes from control subjects will allow us to study the role of extracellular factors in inducing insulin resistance. For this purpose the effects of insulin, glucose and """"""""putative"""""""" serum factor(s) on various insulin actions will be determined. Finally, we will restudy insulin sensitivity and responsiveness in our patients eighteen months after surgery following weight loss and glycemic control and in age, weight and sex matched subjects with and without NIDDM. The significance of this proposal is enhanced by the recognition that these in vitro data from adipocytes will be correlated with those from muscle and liver and in vivo insulin sensitivity. It is hoped that this work will not only establish the cellular basis of insulin resistance in NIDDM and obesity but may help in dissecting the primary and secondary defects of NIDDM, and thus help to develop a more rational therapeutic approach to this major health problem.

Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1989
Total Cost
Indirect Cost
Name
East Carolina University
Department
Type
DUNS #
City
Greenville
State
NC
Country
United States
Zip Code
27858
Friedman, J E; Caro, J F; Pories, W J et al. (1994) Glucose metabolism in incubated human muscle: effect of obesity and non-insulin-dependent diabetes mellitus. Metabolism 43:1047-54
Long, S D; O'Brien, K; MacDonald Jr, K G et al. (1994) Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study. Diabetes Care 17:372-5
Elton, C W; Tapscott, E B; Pories, W J et al. (1994) Effect of moderate obesity on glucose transport in human muscle. Horm Metab Res 26:181-3
Houmard, J A; Shinebarger, M H; Dolan, P L et al. (1993) Exercise training increases GLUT-4 protein concentration in previously sedentary middle-aged men. Am J Physiol 264:E896-901
Houmard, J A; Hortobagyi, T; Neufer, P D et al. (1993) Training cessation does not alter GLUT-4 protein levels in human skeletal muscle. J Appl Physiol 74:776-81
Contreras, I; Caro, J F; Aveledo, L et al. (1992) In chronic uremia, insulin activates receptor kinase but not pyruvate dehydrogenase. Nephron 61:77-81
Pories, W J; MacDonald Jr, K G; Flickinger, E G et al. (1992) Is type II diabetes mellitus (NIDDM) a surgical disease? Ann Surg 215:633-42;discussion 643
Barakat, H A; McLendon, V D; Marks, R et al. (1992) Influence of morbid obesity and non-insulin-dependent diabetes mellitus on high-density lipoprotein composition and subpopulation distribution. Metabolism 41:37-41
Pories, W J; MacDonald Jr, K G; Morgan, E J et al. (1992) Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr 55:582S-585S
Spiegelman, D; Israel, R G; Bouchard, C et al. (1992) Absolute fat mass, percent body fat, and body-fat distribution: which is the real determinant of blood pressure and serum glucose? Am J Clin Nutr 55:1033-44

Showing the most recent 10 out of 48 publications